These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 202533

  • 41. Further evidence on lymphocyte resistance of tumor-bearing in vitro rats to phytohemagglutinin.
    Babusíková O, Novotná L.
    Neoplasma; 1975; 22(6):639-46. PubMed ID: 1214925
    [Abstract] [Full Text] [Related]

  • 42. Impaired synthesis of liver catalase in tumor-bearing rats.
    Kashiwagi K, Tobe T, Higashi T, Warabioka K.
    Gan; 1972 Feb; 63(1):57-62. PubMed ID: 4339713
    [No Abstract] [Full Text] [Related]

  • 43. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,.
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Altered lymphocyte functions in rats bearing syngeneic Moloney sarcoma tumors. I. Mitogen responses, mixed lymphocyte reactions (MLR) and mixed lymphocyte-tumor reactions (MLTR).
    Veit BC, Feldman JD.
    J Immunol; 1976 Aug; 117(2):646-54. PubMed ID: 133190
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Lysosomal accumulation of gallium-67 in Morris hepatoma-7316A and Shionogi mammary carcinoma-115.
    Takeda S, Okuyama S, Takusagawa K, Matsuzawa T.
    Gan; 1978 Apr; 69(2):267-71. PubMed ID: 210077
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. In vitro assay of catalase-depressing activity of toxohormone in cultured liver cells.
    Akiyoshi H, Jikuya K, Fujii S.
    Gan; 1976 Dec; 67(6):923-4. PubMed ID: 1021514
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Comparative studies on the biological effect of toxohormone and bacterial lipopolysaccharide.
    Fukuda M, Okada K, Akikawa K, Matsuda M, Urushizaki I.
    Gan; 1966 Feb; 57(1):27-36. PubMed ID: 5956660
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
    Cercek L, Cercek B.
    Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Toxohormone from normal tissues.
    Olivares J, Callao V, Montoya E.
    Science; 1967 Jul 21; 157(3786):327-8. PubMed ID: 6028404
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.